Preclinical development of a biological antiviral for universal influenza treatment and prophylaxis using a novel nucleic acid delivery platform
Ended Project Grant Awarded Last action
- Award ID
- R44AI140243
- Recipient
-
Sivec Biotechnologies, Inc. UEI FYNKLBVS5LY4
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $6,088,184
Award facts
- Assistance listing
- 93.855 Allergy and Infectious Diseases Research
- Completion date
- Originally
- Funding
-
- $5,068,462.00 Federal
- $1,019,722.00 Non-federal
- Place of performance
- Colorado, USA
Award details come from USAspending.gov.
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | $0 | $0 | |
| Amendment | $1,000,088 | $0 | |
| Amendment | $1,000,088 | $0 | |
| Amendment | $1,019,722 | $0 | |
| Amendment | $1,019,722 | $1,019,722 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $28,842 | $0 | |
| Original award | $1,000,000 | $0 |
Quick answers
Who received award R44AI140243?
R44AI140243 was awarded to Sivec Biotechnologies, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 20, 2018.
How much is award R44AI140243 worth?
$6,088,184 has been obligated on R44AI140243: $5,068,462 in federal funding and $1,019,722 in non-federal funding.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award